Biotechnology

Techseriesinsight > Blog > News > Biotechnology

September 15, 2025
Business Wire
Biotechnology, Healthcare, News

Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today it has enrolled the first patient in a multi-country Phase 2 trial...

September 12, 2025
PRNewswire
Biotechnology, News

Kanazawa University research: Thermal trigger

Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in ACS Nano, how proteins in cells can be controllably activated through heating, an effect that can be used to initiate programmed...

September 11, 2025
PRNewswire
Biotechnology, News

PhenoVista Biosciences and Carolina Molecular Announce Partnership to Extend Multi-omic Data Access to Clients

PhenoVista Biosciences and Carolina Molecular announce a partnership to combine their complementary CRO service capabilities to expand client access to broader multi-omic data. PhenoVista is a premier provider of...

September 11, 2025
PRNewswire
Biotechnology, Healthcare, News

Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led by Professor Sudha Rao at QIMR Berghofer. In this ex vivo study,...

September 5, 2025
Business Wire
Biotechnology, Healthcare, News

Nature Medicine Publishes Phase 3 Data on Pridopidine in Early-Stage Huntington’s Disease, Highlighting Impact on Clinical Progression

Prilenia Therapeutics B.V. and Ferrertoday announced the publication, in the journal Nature Medicine, of a manuscript entitled “Pridopidine in Early-Stage Manifest Huntington Disease: A Phase 3 Trial”ii. The publication describes data...

September 3, 2025
Business Wire
Biotechnology, Healthcare, News

Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease

C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is proud to announce that its early achievements while based in St. Louis are...

September 2, 2025
Business Wire
Biotechnology, News

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”) today announced that it has entered into a licensing agreement for an innovative processing accelerator designed to expedite compute-intensive computations...

August 21, 2025
Business Wire
Artificial Intelligence, Biotechnology, Data Management Platform, Healthcare, News

eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

eClinical Solutions LLC, a global provider of digital clinical software and services, today introduced a digitized Integrated Data Review Plan (IDRP), which further enhances the elluminate Clinical Data Cloud® as a comprehensive,...

August 20, 2025
Business Wire
Biotechnology, Healthcare, News

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million...

August 19, 2025
Business Wire
Biotechnology, Healthcare, News

Twist Bioscience Oncology DNA CGP Panel

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic...